Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed or suspected epithelial cancer Undergoing primary or interval cytoreductive surgery willing to sign written informed consent
Exclusion criteria
Exclusion criteria: Severe infection, hematological disease, autoimmune disease and other malignant tumours liver cancer, liver cirrhosis, hepatitis or other liver illness any history of venous thromboembolism or coagulopathies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete cytoreduction rates and post operative complicationsTimepoint: Baseline, 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Optimal cut-off value for CONUT & FA scores Clinicopathological characteristics Recurrence free survivalTimepoint: Baseline | — |
Countries
India
Contacts
Department of Obs & Gynae, All India Institute of Medical Science New Delhi